Literature DB >> 14718645

Incorporation of the genetic control of alcohol dehydrogenase into a physiologically based pharmacokinetic model for ethanol in humans.

Lester G Sultatos1, Gina M Pastino, Clint A Rosenfeld, Edward J Flynn.   

Abstract

The assessment of the variability of human responses to foreign chemicals is an important step in characterizing the public health risks posed by nontherapeutic hazardous chemicals and the risk of encountering adverse reactions with drugs. Of the many sources of interindividual variability in chemical response identified to date, hereditary factors are some of the least understood. Physiologically based pharmacokinetic modeling linked with Monte Carlo sampling has been shown to be a useful tool for the quantification of interindividual variability in chemical disposition and/or response when applied to biological processes that displayed single genetic polymorphisms. The present study has extended this approach by modeling the complex hereditary control of alcohol dehydrogenase, which includes polygenic control and polymorphisms at two allelic sites, and by assessing the functional significance of this hereditary control on ethanol disposition. The physiologically based pharmacokinetic model for ethanol indicated that peak blood ethanol levels and time-to-peak blood ethanol levels were marginally affected by alcohol dehydrogenase genotypes, with simulated subjects possessing the B2 subunit having slightly lower peak blood ethanol levels and shorter times-to-peak blood levels compared to subjects without the B2 subunit. In contrast, the area under the curve (AUC) of the ethanol blood decay curve was very sensitive to alcohol dehydrogenase genotype, with AUCs from any genotype including the ADH1B2 allele considerably smaller than AUCs from any genotype without the ADH1B2 allele. Furthermore, the AUCs in the ADH1C1/C1 genotype were moderately lower than the AUCs from the corresponding ADH1C2/C2 genotype. Moreover, these simulations demonstrated that interindividual variability of ethanol disposition is affected by alcohol dehydrogenase and that the degree of this variability was a function of the ethanol dose.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14718645     DOI: 10.1093/toxsci/kfh057

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  4 in total

1.  Physiologically based pharmacokinetic (PBPK) models for ethanol.

Authors:  Martin H Plawecki; Jae-Joon Han; Peter C Doerschuk; Vijay A Ramchandani; Sean J O'Connor
Journal:  IEEE Trans Biomed Eng       Date:  2008-12       Impact factor: 4.538

2.  MEGen: A Physiologically Based Pharmacokinetic Model Generator.

Authors:  George Loizou; Alex Hogg
Journal:  Front Pharmacol       Date:  2011-11-10       Impact factor: 5.810

Review 3.  Issues in assessing the health risks of n-butanol.

Authors:  Deborah Segal; Ambuja S Bale; Linda J Phillips; Alan Sasso; Paul M Schlosser; C Starkey; Susan L Makris
Journal:  J Appl Toxicol       Date:  2019-06-24       Impact factor: 3.628

4.  Association Study of Alcohol Dehydrogenase and Aldehyde Dehydrogenase Polymorphism With Alzheimer Disease in the Taiwanese Population.

Authors:  Yah-Yuan Wu; Yun-Shien Lee; Yu-Li Liu; Wen-Chuin Hsu; Wei-Min Ho; Yu-Hua Huang; Shih-Jen Tsai; Po-Hsiu Kuo; Yi-Chun Chen
Journal:  Front Neurosci       Date:  2021-01-22       Impact factor: 4.677

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.